These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27188504)

  • 1. Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.
    Wijermars LG; Schaapherder AF; de Vries DK; Verschuren L; Wüst RC; Kostidis S; Mayboroda OA; Prins F; Ringers J; Bierau J; Bakker JA; Kooistra T; Lindeman JH
    Kidney Int; 2016 Jul; 90(1):181-91. PubMed ID: 27188504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed graft function and its management in children.
    Grenda R
    Pediatr Nephrol; 2017 Jul; 32(7):1157-1167. PubMed ID: 27778091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation.
    Jansen MPB; Pulskens WPC; Uil M; Claessen N; Nieuwenhuizen G; Standaar D; Hau CM; Nieuwland R; Florquin S; Bemelman FJ; Leemans JC; Roelofs JJTH
    Nephrol Dial Transplant; 2020 Aug; 35(8):1320-1327. PubMed ID: 30590723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein levels of heme oxygenase-1 during reperfusion in human kidney transplants with delayed graft function.
    Ollinger R; Kogler P; Biebl M; Sieb M; Sucher R; Bösmüller C; Troppmair J; Mark W; Weiss H; Margreiter R
    Clin Transplant; 2008; 22(4):418-23. PubMed ID: 18261117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function.
    Wohlfahrtova M; Brabcova I; Zelezny F; Balaz P; Janousek L; Honsova E; Lodererova A; Wohlfahrt P; Viklicky O
    Transplantation; 2014 Jan; 97(2):176-83. PubMed ID: 24092381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factor-1α Expression in Kidney Transplant Biopsy Specimens After Reperfusion Is Associated With Early Recovery of Graft Function After Cadaveric Kidney Transplantation.
    Oda T; Ishimura T; Yokoyama N; Ogawa S; Miyake H; Fujisaw M
    Transplant Proc; 2017; 49(1):68-72. PubMed ID: 28104162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cytokine concentrations in graft renal vein during reperfusion in patients with and without delayed graft function.
    Domański L; Pawlik A; Safranow K; Rozański J; Myślak M; Sulikowski T; Romanowski M; Ostrowski M; Wiśniewska M; Domański M; Kabat-Koperska J; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):49-52. PubMed ID: 19127809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injury.
    Wijermars LG; Bakker JA; de Vries DK; van Noorden CJ; Bierau J; Kostidis S; Mayboroda OA; Tsikas D; Schaapherder AF; Lindeman JH
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F457-F464. PubMed ID: 28031169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of arteriolar hyalinosis in post-reperfusion biopsies represents an additional risk to ischaemic injury in renal transplant.
    Matos AC; Câmara NO; REQUIãO-Moura LR; Tonato EJ; Filiponi TC; Souza-DURãO M; Malheiros DM; Fregonesi M; Borrelli M; Pacheco-Silva A
    Nephrology (Carlton); 2016 Nov; 21(11):923-929. PubMed ID: 26661292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury.
    Lindeman JH; Wijermars LG; Kostidis S; Mayboroda OA; Harms AC; Hankemeier T; Bierau J; Sai Sankar Gupta KB; Giera M; Reinders ME; Zuiderwijk MC; Le Dévédec SE; Schaapherder AF; Bakker JA
    Kidney Int; 2020 Dec; 98(6):1476-1488. PubMed ID: 32781105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.
    Domański L; Kłoda K; Kwiatkowska E; Borowiecka E; Safranow K; Drozd A; Ciechanowicz A; Ciechanowski K
    BMC Nephrol; 2015 Feb; 16():23. PubMed ID: 25884882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative release of pro-regenerative biochemical signals from human renal allografts subjected to ischemia-reperfusion injury.
    Błogowski W; Dolegowska B; Budkowska M; Sałata D; Domański L; Starzynska T
    Innate Immun; 2014 Feb; 20(2):126-32. PubMed ID: 23608824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.
    Heilman RL; Smith ML; Smith BH; Qaqish I; Khamash H; Singer AL; Kaplan B; Reddy KS
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2225-2232. PubMed ID: 27797897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological Features and Role of Allograft Kidney Biopsy Among Recipients With Prolonged Delayed Graft Function: A Review.
    Swanson KJ; Zhong W; Mandelbrot DA; Parajuli S
    Transplantation; 2024 Sep; 108(9):1911-1921. PubMed ID: 38383958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.
    Yu ZX; Qi S; Lasaro MA; Bouchard K; Dow C; Moore K; Wu Z; Barama A; Xu J; Johnson K; Marozsan AJ; Wang Y
    Am J Transplant; 2016 Sep; 16(9):2589-97. PubMed ID: 27003920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.